Cargando…

Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review

INTRODUCTION: The prognosis for recurrent intrahepatic cholangiocarcinoma with bone metastasis remains dismal and its treatment poses a challenge for oncologists. To date, only 2 cases were reported in which pembrolizumab, an agent against programmed cell death protein-1 (PD-1), combined with chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-xun, Li, Gan-xun, Hu, Zheng-nan, Zhu, Peng, Zhang, Bi-xiang, Ding, Ze-yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855517/ https://www.ncbi.nlm.nih.gov/pubmed/31702638 http://dx.doi.org/10.1097/MD.0000000000017832

Ejemplares similares

Comparison analysis of PD-1/PD-L1 inhibitors plus lenvatinib or gemcitabine/cisplatin as first-line treatment for patients with advanced intrahepatic cholangiocarcinoma
por: Huang, Jia-Xin, et al.
Publicado: (2023)

Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer: A meta-analysis
por: Zhang, Pei-Pei, et al.
Publicado: (2021)

Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
por: Li, Fenghu, et al.
Publicado: (2019)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
por: Xie, Lulu, et al.
Publicado: (2022)

Predictive factors for clinically significant pharmacist interventions at hospital admission
por: Mongaret, Céline, et al.
Publicado: (2018)

Efficacy of tranexamic acid plus drain-clamping to reduce blood loss in total knee arthroplasty: A meta-analysis
por: Zhang, Yan, et al.
Publicado: (2017)

Anti-EGFR monoclonal antibody plus chemotherapy for treating advanced non-small cell lung cancer: A meta-analysis
por: Luo, Wenqing, et al.
Publicado: (2021)

Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction
por: Zhang, Jian-Jun, et al.
Publicado: (2018)

Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis
por: Luo, Fang, et al.
Publicado: (2021)

Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review
por: Gu, Wei-Jun, et al.
Publicado: (2017)

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
por: Zhang, Wei, et al.
Publicado: (2023)

A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis
por: Jiang, Tian-Yue, et al.
Publicado: (2021)

The effectiveness and safety of tranexamic acid in bilateral total knee arthroplasty: A meta-analysis
por: Weng, Kedi, et al.
Publicado: (2016)

Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization
por: Luo, Xin, et al.
Publicado: (2023)

Mapping the knowledge domains of medical textiles: A review
por: Liu, Zhiqun, et al.
Publicado: (2023)

M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
por: Yang, Long, et al.
Publicado: (2023)

Efficacy and safety of Aprepitant-containing triple therapy for the prevention and treatment of chemotherapy-induced nausea and vomiting: A meta-analysis
por: Zhang, Min, et al.
Publicado: (2023)

Pharmaceutical care of rituximab in the treatment of children with refractory anti-NMDAR encephalitis: A case report
por: Wu, Haiyan, et al.
Publicado: (2023)

Diagnostic value of serum human epididymis protein 4 and cancer antigen 125 in the patients with ovarian carcinoma: A protocol for systematic review and meta-analysis
por: Dai, Hai-Ying, et al.
Publicado: (2021)

Network pharmacology-based screening of the active ingredients and mechanisms of Huangqi against aging
por: Lan, Siyu, et al.
Publicado: (2021)

Bisphenol A and Hormone-Associated Cancers: Current Progress and Perspectives
por: Gao, Hui, et al.
Publicado: (2015)

Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion: A case report
por: Huang, Jing, et al.
Publicado: (2018)

Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis
por: Li, Bingxue, et al.
Publicado: (2021)

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
por: Zhu, Chengpei, et al.
Publicado: (2023)

Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case Report
por: Liu, Ze-Long, et al.
Publicado: (2020)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy
por: Ding, Yuan, et al.
Publicado: (2021)

Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review
por: Huang, Peixin, et al.
Publicado: (2021)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma
por: Gong, Yinhua, et al.
Publicado: (2023)

Comparing Characteristics of Adverse Drug Events Between Older and Younger Adults Presenting to a Taiwan Emergency Department
por: Chen, Yen-Chia, et al.
Publicado: (2015)

Adjuvant therapy use among Appalachian breast cancer survivors
por: Tan, Xi, et al.
Publicado: (2015)

Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study
por: Chung, Wei-Sheng, et al.
Publicado: (2015)

Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics: A Population-Based Retrospective Cohort Study
por: Lin, Chia-Ling, et al.
Publicado: (2015)

Safety and Efficacy of Sodium Hyaluronate Gel and Chitosan in Preventing Postoperative Peristomal Adhesions After Defunctioning Enterostomy: A Prospective Randomized Controlled Trials
por: Hu, Jiancong, et al.
Publicado: (2015)

Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2016)

Atrial Fibrillation is Associated With Morphine Treatment in Female Breast Cancer Patients: A Retrospective Population-Based Time-Dependent Cohort Study
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2016)

Comparison of Doxorubicin Anticancer Drug Loading on Different Metal Oxide Nanoparticles
por: Javed, Khalid Rashid, et al.
Publicado: (2015)

Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes: An Investigation of the Regulator in Japan
por: Sato, Ryosuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5u5p71tc83483i0vukcjiu1ct5